Table 4.
Multivariate analysis of the correlation between clinicopathological parameters and overall survival time of patients with gastric cancer.
| Covariates | HR | 95% CI for HR | P |
|---|---|---|---|
| Gender (Male vs. Female) | 0.913 | 0.579–1.439 | 0.694 |
| Age (≥60 vs. <60 cm) | 1.080 | 0.718–1.624 | 0.713 |
| Tumor size (≥5 vs. <5 cm) | 0.839 | 0.548–1.284 | 0.418 |
| Borrmann type (type I, II vs. III, IV) | 1.075 | 0.691–1.672 | 0.748 |
| Degree of differentiation | 0.728 | 0.475–1.114 | 0.144 |
| Histological type | 1.759 | 0.920–3.363 | 0.088 |
| Depth of invasion (T3, T4 vs. T1, T2) | 0.236 | 0.088–0.638 | 0.004 |
| Lymph node metastasis | 0.333 | 0.156–0.711 | 0.005 |
| TNM stage (stage I vs. II vs. III vs. IV) | 1.911 | 0.851–4.292 | 0.117 |
| Prdx 1 expression (low vs. high) | 0.411 | 0.242–0.700 | 0.001 |
| E-Ca expression (low vs. high) | 1.698 | 1.082–2.664 | 0.021 |